131 related articles for article (PubMed ID: 10897069)
1. Oka varicella vaccine is distinguishable from its parental virus in DNA sequence of open reading frame 62 and its transactivation activity.
Gomi Y; Imagawa T; Takahashi M; Yamanishi K
J Med Virol; 2000 Aug; 61(4):497-503. PubMed ID: 10897069
[TBL] [Abstract][Full Text] [Related]
2. Comparison of DNA sequence and transactivation activity of open reading frame 62 of Oka varicella vaccine and its parental viruses.
Gomi Y; Imagawa T; Takahashi M; Yamanishi K
Arch Virol Suppl; 2001; (17):49-56. PubMed ID: 11339550
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the complete DNA sequences of the Oka varicella vaccine and its parental virus.
Gomi Y; Sunamachi H; Mori Y; Nagaike K; Takahashi M; Yamanishi K
J Virol; 2002 Nov; 76(22):11447-59. PubMed ID: 12388706
[TBL] [Abstract][Full Text] [Related]
4. Comparison of virus transcription during lytic infection of the Oka parental and vaccine strains of Varicella-Zoster virus.
Cohrs RJ; Gilden DH; Gomi Y; Yamanishi K; Cohen JI
J Virol; 2006 Mar; 80(5):2076-82. PubMed ID: 16474115
[TBL] [Abstract][Full Text] [Related]
5. Analysis of IE62 mutations found in Varicella-Zoster virus vaccine strains for transactivation activity.
Ko H; Lee GM; Shin OS; Song MJ; Lee CH; Kim YE; Ahn JH
J Microbiol; 2018 Jun; 56(6):441-448. PubMed ID: 29858833
[TBL] [Abstract][Full Text] [Related]
6. Molecular analysis of the Oka vaccine strain of varicella-zoster virus.
Yamanishi K
J Infect Dis; 2008 Mar; 197 Suppl 2():S45-8. PubMed ID: 18419407
[TBL] [Abstract][Full Text] [Related]
7. Nucleotide sequences that distinguish Oka vaccine from parental Oka and other varicella-zoster virus isolates.
Argaw T; Cohen JI; Klutch M; Lekstrom K; Yoshikawa T; Asano Y; Krause PR
J Infect Dis; 2000 Mar; 181(3):1153-7. PubMed ID: 10720545
[TBL] [Abstract][Full Text] [Related]
8. New method of differentiating wild-type varicella-zoster virus (VZV) strains from Oka varicella vaccine strain by VZV ORF 6-based PCR and restriction fragment length polymorphism analysis.
Takayama M; Takayama N
J Clin Virol; 2004 Feb; 29(2):113-9. PubMed ID: 14747030
[TBL] [Abstract][Full Text] [Related]
9. The attenuated genotype of varicella-zoster virus includes an ORF0 transitional stop codon mutation.
Peters GA; Tyler SD; Carpenter JE; Jackson W; Mori Y; Arvin AM; Grose C
J Virol; 2012 Oct; 86(19):10695-703. PubMed ID: 22837206
[TBL] [Abstract][Full Text] [Related]
10. Sequencing and characterization of Varicella-zoster virus vaccine strain SuduVax.
Kim JI; Jung GS; Kim YY; Ji GY; Kim HS; Wang WD; Park HS; Park SY; Kim GH; Kwon SN; Lee KM; Ahn JH; Yoon Y; Lee CH
Virol J; 2011 Dec; 8():547. PubMed ID: 22176950
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the Whole-Genome Sequence of an Oka Varicella Vaccine from China with Other Oka Vaccine Strains Reveals Sites Putatively Critical for Vaccine Efficacy.
Wu Q; Rivailler P; Xu S; Xu W
J Virol; 2019 May; 93(9):. PubMed ID: 30728261
[TBL] [Abstract][Full Text] [Related]
12. Mutational analysis of open reading frames 62 and 71, encoding the varicella-zoster virus immediate-early transactivating protein, IE62, and effects on replication in vitro and in skin xenografts in the SCID-hu mouse in vivo.
Sato B; Ito H; Hinchliffe S; Sommer MH; Zerboni L; Arvin AM
J Virol; 2003 May; 77(10):5607-20. PubMed ID: 12719553
[TBL] [Abstract][Full Text] [Related]
13. Comparative analyses of the 9 glycoprotein genes found in wild-type and vaccine strains of varicella-zoster virus.
Storlie J; Maresova L; Jackson W; Grose C
J Infect Dis; 2008 Mar; 197 Suppl 2():S49-53. PubMed ID: 18419408
[TBL] [Abstract][Full Text] [Related]
14. [Genetic analysis of clinical varicella-zoster virus isolates collected in China].
Gan L; Wang ML; Zhao J; Chen JX
Zhonghua Liu Xing Bing Xue Za Zhi; 2010 Feb; 31(2):189-93. PubMed ID: 21215082
[TBL] [Abstract][Full Text] [Related]
15. Novel genetic variation identified at fixed loci in ORF62 of the Oka varicella vaccine and in a case of vaccine-associated herpes zoster.
Quinlivan ML; Jensen NJ; Radford KW; Schmid DS
J Clin Microbiol; 2012 May; 50(5):1533-8. PubMed ID: 22378912
[TBL] [Abstract][Full Text] [Related]
16. A major transactivator of varicella-zoster virus, the immediate-early protein IE62, contains a potent N-terminal activation domain.
Perera LP; Mosca JD; Ruyechan WT; Hayward GS; Straus SE; Hay J
J Virol; 1993 Aug; 67(8):4474-83. PubMed ID: 8392592
[TBL] [Abstract][Full Text] [Related]
17. Genetic profile of an Oka varicella vaccine virus variant isolated from an infant with zoster.
Sauerbrei A; Rubtcova E; Wutzler P; Schmid DS; Loparev VN
J Clin Microbiol; 2004 Dec; 42(12):5604-8. PubMed ID: 15583288
[TBL] [Abstract][Full Text] [Related]
18. Improved identification and differentiation of varicella-zoster virus (VZV) wild-type strains and an attenuated varicella vaccine strain using a VZV open reading frame 62-based PCR.
Loparev VN; Argaw T; Krause PR; Takayama M; Schmid DS
J Clin Microbiol; 2000 Sep; 38(9):3156-60. PubMed ID: 10970349
[TBL] [Abstract][Full Text] [Related]
19. Vaccine-type mutations identified in Varicella zoster virus passaged in cell culture.
Kim SC; Won YH; Park JS; Jeon JS; Ahn JH; Song MJ; Shin OS; Lee CH
Virus Res; 2018 Feb; 245():62-68. PubMed ID: 29242077
[TBL] [Abstract][Full Text] [Related]
20. Differentiation of wild-type varicella-zoster strains from India and the Oka vaccine strain using a VZV open reading frame - 62 based PCR-RFLP technique.
Kaushik KS; Lahiri KK; Kapila K; Kumar S; Gupta RM; Karade S
Braz J Infect Dis; 2008 Aug; 12(4):313-5. PubMed ID: 19030732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
